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Introduction {#Sec1}
============

Rhesus macaques are frequently used as important animal models for the study of human infectious and autoimmune diseases, in transplantation studies, and vaccine development. As is known from other species, also the rhesus macaque *MHC* (*Mamu*) is associated with susceptibility and resistance to infectious and autoimmune diseases (Goulder and Watkins [@CR10]; Sauermann et al. [@CR26]; Vierboom et al. [@CR30]). Significant progress has been made in the last years in the analysis of such disease associations, yet many of the various identified *MHC class I* genes have not been functionally characterised. The reason for this may be that the rhesus macaque *MHC class I* gene region is highly prone to gene expansions and contractions. While genes orthologous to *HLA-E* and *HLA-F* are present, rhesus macaques show extensive duplications of *class I* genes that are assigned to the *MHC-A*, *MHC-B* and *MHC-G* lineages (Daza-Vamenta et al. [@CR7]; Kulski et al. [@CR16]; Otting et al. [@CR23]; Otting et al. [@CR22]). Four distinct *Mamu-A* and \>20 distinct *Mamu-B* genes were described in Indian rhesus macaques (Daza-Vamenta et al. [@CR7]; Otting et al. [@CR23]; Otting et al. [@CR22]). A strict orthologue of *HLA-C* is absent from the rhesus macaque *MHC* and the duplicated *Mamu-G* genes are pseudogenes (Daza-Vamenta et al. [@CR7]). The function of *Mamu-G* was likely replaced by duplicated *Mamu-AG* genes that show characteristics of both *Mamu-A* and *Mamu-G* (Boyson et al. [@CR5]). Further contributing to this complex genomic situation are highly variable numbers of *class I* genes in rhesus macaque *MHC class I* haplotypes, i.e., haplotypes show differential gene content. In addition, the classical class I gene *Mamu-A1* exhibits considerable allelic polymorphism (Blasky et al. [@CR2]; Karl et al. [@CR15]), although to much smaller extent as compared to classical *HLA class I* genes. Blocks of repetitive elements in which the single *class I* gene units are embedded (Bonhomme et al. [@CR3]; Bonhomme et al. [@CR4]; Kulski et al. [@CR16]) substantially enhance unequal crossing-over events during meiosis, giving rise to differences in gene content. Such mechanisms are typical examples of 'birth and death' processes in *MHC class I* gene evolution (Nei et al. [@CR20]).

Four and seven *Mamu-A* genes have been defined in rhesus macaques of Indian and Chinese origin, respectively (Blasky et al. [@CR2]; Karl et al. [@CR15]; Otting et al. [@CR23]; Otting et al. [@CR22]). These genes differ in their degrees of polymorphism and in transcriptional activity. Whereas alleles of the *Mamu-A1* gene were so far found on every haplotype, differential gene content is evident for *Mamu-A2*, *Mamu-A3* and *Mamu-A4*, which are less polymorphic and transcribed to lower extent (Otting et al. [@CR23]). The *Mamu-B* subregion displays even a higher degree of complexity, as shown by genomic sequencing of a complete *Mamu* haplotype (Daza-Vamenta et al. [@CR7]) and by cDNA cloning and segregation studies in rhesus macaque families (Otting et al. [@CR22]; Otting et al. [@CR24]). Based on promotor and exon/intron structure only 14 of the 19 *Mamu-B* genes of the sequenced haplotype are expected to be transcribed, but only seven of them were found by cDNA analysis. These genes also include the so-called *Mamu-I* genes that are members of the *Mamu-B* gene subfamily and were previously designated *Mamu-B\*09* (Urvater et al. [@CR29]). *Mamu-I* genes are characterised by low variability and low expression of their gene products on the cell surface upon transfection (Urvater et al. [@CR29]). According to the number of clones found by cDNA cloning, the transcribed *Mamu-B* genes are distinguished into 'major and minor expressors' (Otting et al. [@CR24]).

Data on protein expression of certain Mamu-A and most Mamu-B molecules are largely lacking. Antigen presentation has been extensively studied for *Mamu-A1* alleles, in particular for allele *Mamu-A1\*001*, which confers slow progression to AIDS and low viral loads upon experimental infection with the simian immunodeficiency virus (SIVmac). In addition, antigen presentation was described for Mamu-B\*001, B\*003, B\*008, B\*012 and B\*017 (Goulder and Watkins [@CR10]; Hickman-Miller et al. [@CR14]; Loffredo et al. [@CR17]; Mothe et al. [@CR18]; Voss and Letvin [@CR31]). Here, we have established various expression constructs for Mamu-A and Mamu-B molecules with a carboxy-terminal AcGFP tag and studied their subcellular expression in MHC class I negative K562 cells by confocal laser microscopy and flow cytometry. We found classical surface expression for all Mamu-A molecules except Mamu-A4\*01403 and divergent subcellular expression patterns for Mamu-B molecules. Our data indicate that some Mamu-B molecules are not loaded with peptides and therefore remain predominantly inside the cell.

Materials and methods {#Sec2}
=====================

PBMC samples {#Sec3}
------------

Blood samples were obtained during regular veterinary inspections of 30 Indian rhesus macaques housed in the German Primate Centre. Peripheral blood mononuclear cells (PBMC) were obtained after ficoll gradient centrifugation for 45 min.

RNA isolation, cDNA synthesis, RT-PCR and cloning of *MHC class I* and *B2M* cDNA {#Sec4}
---------------------------------------------------------------------------------

All rhesus macaque PBMC samples were pooled and total RNA was isolated with a Qiagen RNA Mini purification kit (Qiagen, Hilden, Germany). Complementary DNA (cDNA) was synthesised with oligo-dT primer and murine leukaemia virus reverse transcriptase (M-MLV-RT) (Promega, Mannheim, Germany). Polymerase chain reaction (PCR) was performed to amplify *MHC class I* cDNA and rhesus macaque *Β2M* (mmB2M) cDNA using BioTherm Taq DNA Polymerase (Genecraft, Cologne, Germany) with primer pairs for *Mamu-A* (Mamu-A-*EcoRI*-forward: GCTC[GAATTC]{.ul}CAAGGATGGCGCCCCGAACCCT, Mamu-A-*BamHI*-reverse: GATAA[GGATCC]{.ul}TCCACTTTACAAGCCATAAGAGA), *Mamu-B* (Mamu-B-*HindIII*-forward: GCTC[AAGCTT]{.ul}CGGTCATGCGGGTCATGGCGCCCC, Mamu-B-*KpnI*-reverse: CGTA[GGTACC]{.ul}TTAGCCGTGAGAGACACATCA), *Mamu-I* (Mamu-I-*HindIII*-forward: GCTC[AAGCTT]{.ul}CGGTCATGCGGGTCATGGCGCCCG, Mamu-I-*KpnI*-reverse: CGTA[GGTACC]{.ul}CAAGCTGTGAGAGACACATCAG), and mmB2M (mmB2M-forward: CGAGATGTCTCGCTCAGTG, mmB2M-reverse: TGACATGTCTCGATCCCACTT). *HLA-C*-specific PCR was performed using primers HLA-C-*HindIII*-forward: CAT[AAGCTT]{.ul}CGAGATGCGGGTCATGGCGC and HLA-C-*KpnI*-reverse: GTA[GGTACC]{.ul}TGGGCTTTACAAGCGATGAGAGACT. Restriction sites introduced in primers for cloning of *MHC class I* cDNA in the expression vector pAcGFP-N1 are underlined. PCRs were performed with a Labcycler (SensoQuest, Göttingen, Germany) and the following parameters were used: initial denaturation at 94°C for 4 min, 30 cycles of 94°C for 60 s (30 s for mmB2M), 60°C (62°C for *HLA-C*) for 60 s (30 s for mmB2M) and 72°C for 90 s (60 s for mmB2M), followed by a final extension for 72°C for 5 min. PCR products were analysed by agarose gel electrophoresis and purified with the Wizard® SV Gel and PCR Clean-Up System (Promega). *MHC class I* and mmB2M PCR products were cloned in the pGEM-T Easy vector (Promega) and pcDNA3.1/V5-His-TOPO TA expression vector (Invitrogen, Carlsbad, CA, USA), respectively. Isolated plasmids were sequenced with BigDye terminator cycle sequencing chemistry and samples were analysed in an ABI 3130xl automatic sequencer (Applied Biosystems, Foster City, CA, USA). *MHC class I* cDNA clones with identical sequences that were found at least three times were used for subcloning in the pAcGFP-N1 expression vector (Clontech, Carlsbad, CA, USA).

Establishment of chimeric and mutated Mamu class I constructs {#Sec5}
-------------------------------------------------------------

Chimeric constructs of *Mamu-I\*010201* and *Mamu-B\*06002* were established by PCR, exchanging either exon 2 or exon 3 or both exons. Forward and reverse primers at the ends of exons 2 and 3 were constructed (α1 exchange F: GGGTCTCACACCCTCCAG; α1 exchange R: GGAGGGTGTGAGACCCC; α1+α2 exchange F: GGATCCCCCAAAGACACAC; α1+α2 exchange R: CTTTGGGGGATCCGCGC). 5′ and 3′ part were amplified from *Mamu-I\*010201*-AcGFP and *Mamu-B\*06002*-AcGFP constructs with one internal primer and one vector primer (pAcGFP F: CAAATGGGCGGTAGGCGTG or pAcGFP R: GTGGCCATTCACATCGCCAT) with proofreading Pfu DNA polymerase (Fermentas, Ontario, Canada). For the exchange of the α2 domain, the α1-exchanged chimeric constructs were used as templates together with the primers for the α1+α2 exchange. PCR products were isolated after gel electrophoresis and used as templates for the generation of chimeric constructs in a further PCR: five cycles without and 25 cycles with pAcGFP vector primers. Obtained PCR products were digested with restriction enzymes *EcoRI* and *KpnI* and ligated into *EcoRI/KpnI*-digested pAcGFP-N1 expression vector.

To establish untagged rhesus macaque MHC class I molecules, the AcGFP tag was removed by site-directed mutagenesis of the AcGFP start codon (AUG) into a stop codon (UGA) in *Mamu-A1\*00101*, *Mamu-A1\*00801*, *Mamu-A1\*01101*, *Mamu-A2\*050402*, *Mamu-A3\*1311*, *Mamu-A4\*1403*, *Mamu-B\*01202*, *Mamu-B\*02101*, *Mamu-B\*02804*, *Mamu-B\*06002*, *Mamu-I\*010201* and *Mamu-I\*0121* expression constructs. Primers introducing the amino acid change (without AcGFP F: CGGGATCCACCGGTCTGAGTGAGCAAGGGCGCC; without AcGFP R: GGCGCCCTTGCTCACTCAGACCGGTGGATCCCG) were used with the QuikChange Multi Site-Directed Mutagenesis Kit according to the manufacturer's recommendations (Stratagene, La Jolla, CA, USA). All chimeric or mutated constructs were finally controlled by sequencing analysis.

Transfection of K562 cells, confocal microscopy and flow cytometry {#Sec6}
------------------------------------------------------------------

K562 cells (human erythromyeloid leukaemia, DSMZ, Germany) were propagated in DMEM medium (PAA, Pasching, Austria), supplemented with 10% inactivated FCS, 100 U/ml penicillin and 0.1 mg/ml streptomycin (PAA). Cells were split 1:3 to 1:5 every second or third day. Cells were routinely tested for presence of mycoplasma using 1 µl of cell culture supernatant as template in a PCR with primers MYCF1: ACACCATGGGAGCTGGTAAT and MYCR1: CTTCWTCGACTTYCAGACCCAAGGCAT followed by a nested PCR with primers MYCF2: GTTCTTTGAAAACTGAAT and MYCR2: GCATCCACCAWAWACTCT.

K562 cells were also transiently transfected using Metafectene reagent according to manufacturer's instructions (Biontex, Martinsried, Germany). Transfection efficiency was controlled 48 h later by fluorescence microscopy via AcGFP fluorescence.

K562 cells were transiently co-transfected with *Mamu-B* and rhesus macaque *B2M* constructs as described above. Expression of V5-tagged B2M was controlled in parallel experiments with mouse anti-V5 monoclonal antibody (Invitrogen) and goat anti-mouse IgG-PE-Cy5 polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA).

Surface expression of MHC class I molecules was verified by confocal microscopy and flow cytometry. Cells (5 × 10^5^) were washed twice with phosphate-buffered saline (1 × PBS) and stained with the anti-MHC class I monoclonal antibody W6/32 (hybridoma HB-95, ATCC) or the anti-B2M monoclonal antibody BBM.1 (sc-13565, Santa Cruz Biotechnology) for 1 h at 4°C. Binding of W6/32 or BBM.1 was detected with a goat anti-mouse IgG-PE-Cy5 polyclonal antibody (SC-3799, Santa Cruz Biotechnology). For microscopy, cells were resuspended in 30 µl 1 × PBS and 10 µl were put on a slide and covered with a cover slip. Pictures were taken immediately to ensure that cells were still alive. All images were collected with confocal laser scanning microscope LSM 5 PASCAL (Zeiss) through ×63 objectives. Images were processed with Photoshop CS software (Adobe, San Jose, CA, USA).

For flow cytometry, cells were resuspended in 200 µl of 1 × PBS and 30,000 events were measured in a LSR II flow cytometer (BD Bioscience, San Jose, USA). Living cells were gated based on forward and side scatter characteristics. Data were acquired with BD FACS Diva 5.1 Software (Becton Dickinson) and subsequently analysed with FlowJo 5.7.1 or 7.5.5 Software (TreeStar, Ashland, OR, USA).

Co-localisation of AcGFP-tagged Mamu-A and Mamu-B molecules with organelle-specific marker molecules {#Sec7}
----------------------------------------------------------------------------------------------------

K562 cells were transiently transfected with *Mamu-A1\*00101* or *Mamu-B\*01202* expression constructs and grown for 48 h in 5% CO~2~ and 37°C. Cells were harvested and washed twice with 1 × PBS followed by fixation with 2% paraformaldehyde for 10 min at room temperature. After two rounds of washing with 1 × PBS, cells were permeabilised with 0.5% Triton X-100 in 1 × PBS for 5 min at room temperature. Non-specific binding was blocked by incubation with 5% bovine serum albumin (BSA) in 1 × PBS for 30 min at room temperature. Antibodies were diluted in 0.5% BSA in 1 × PBS for detection of organelle markers; primary antibodies were applied overnight at 4°C (anti-Calnexin, 1:1,000 (BD Bioscience); anti-GM130 1:250 (BD Bioscience); and anti-LAMP-1 1:25 (clone: H4A3, Developmental Studies Hybridoma Bank, Iowa City, IA, USA)). After washing twice with 1 × PBS, antibody staining was visualised by incubation with a secondary antibody (polyclonal rabbit anti-mouse-TRITC, DAKO, Glostrup, Denmark; 1:40) for 1 h at room temperature. Cells were washed twice with 1 × PBS followed by mounting with fluorescent mounting medium (DAKO). Fluorescent cells were analysed with a confocal laser scanning microscope LSM 5 PASCAL (Zeiss) through × 63 objectives.

Nomenclature and database accession numbers {#Sec8}
-------------------------------------------

Novel cDNA sequences were submitted to DDBJ/EMBL/GenBank database: Mamu-B\*01202 (GQ387655), Mamu-B\*01704 (GQ387656), Mamu-B\*02101 (GQ387657), Mamu-B\*05704 (GQ387658), Mamu-B\*02801 (GQ387659), Mamu-B\*13401 (GQ387661), Mamu-I\*0121 (GQ387662). Sequences were also submitted to the Immunopolymorphism Database IPD (Robinson and Marsh [@CR25]) and received official designations (<http://www.ebi.ac.uk/ipd/mhc/>). As in the meantime numbers of known *Mamu-A1* alleles and *Mamu-B* sequences both exceed 100, the *Mamu-A1* allelic lineages and the various *Mamu-B* sequences are distinguished by the first three digits after the star, e.g., *Mamu-A1\*001* or *Mamu-B\*012*, which were previously designated *Mamu-A1\*01* (or *Mamu-A01*), and *Mamu-B\*12*.

Results and discussion {#Sec9}
======================

We isolated *Mamu-A* and *Mamu-B* cDNAs from a pool of 30 rhesus macaques of Indian origin by RT-PCR cloning. Altogether, 17 different cDNAs were identified, of which six belong to the *Mamu-A* and 11 to the *Mamu-B*/*Mamu-I* lineages. Sixteen of these cDNA sequences were identical (or nearly identical) to already published *Mamu-A* or *Mamu-B/Mamu-I* sequences. One cDNA sequence was less than 96% identical to any of the known rhesus macaque *MHC class I* sequences, likely representing a new gene or allele that received the designation *Mamu-B\*13401* from the Immuno Polymorphism Database (IPD-MHC database). We were interested in studying the cell surface expression of the various *Mamu-A* and *Mamu-B*-encoded molecules. As reactivity of many rhesus macaque MHC class I proteins with mouse anti-human MHC class I monoclonal antibody W6/32 is not known, we fused the *MHC class I* cDNA sequences with *AcGFP* for visualisation in K562 cells. As controls we included K562 cells transfected with AcGFP and AcGFP-tagged HLA-Cw\*0303, respectively.

Expression patterns of Mamu-A and Mamu-B molecules {#Sec10}
--------------------------------------------------

Six Mamu-A molecules were included in our analysis: three alleles of the polymorphic classical *MHC class I* gene *Mamu-A1* (*A1\*00101*, *A1\*00801*, *A1\*01101*) and one allele each of the less polymorphic *Mamu-A2* (*A2\*050402*), *Mamu-A3* (*A3\*1311*) and *Mamu-A4* (*A4\*1403*) genes. Strong cell surface expression was observed with monoclonal antibody W6/32 for the three *Mamu-A1* alleles and for *Mamu-A3\*1311* with a mean fluorescence intensity (MFI) between 540 and 843 (Fig. [1a](#Fig1){ref-type="fig"}) and to lower extend for *Mamu-A2\*050402* (MFI: 326). *Mamu-A4\*1403* revealed the lowest surface expression (MFI: 105) among all Mamu-A molecules. The same tendency in MFI values was observed upon staining of the cells with the anti-β2-microglobulin antibody BBM.1 (Fig. [1b](#Fig1){ref-type="fig"}), indicating that lower MFI values reflect fewer MHC class I molecules on the cell surface and not lower affinity of W6/32 antibody for different Mamu-A molecules. Confocal microscopy of the AcGFP-tagged Mamu-A molecules demonstrated that *A1*, *A2* and *A3*-encoded molecules are mainly found on the cell surface, and only few molecules were detected inside the cell (Fig. [1a](#Fig1){ref-type="fig"}). In contrast, Mamu-A4\*1403 is found mainly inside the cell. Notably, cell surface expression pattern of the studied Mamu-A molecules roughly correlates with known transcription levels of *Mamu-A1* (high), *Mamu-A2* and *Mamu-A3* (medium) and *Mamu-A4* (low) according to data published by Otting and colleagues ([@CR23]). Fig. 1Analysis of Mamu-A and Mamu-B protein expression. **a** K562 cells were transiently transfected with expression constructs encoding AcGFP-tagged Mamu-A, Mamu-B or HLA-Cw\*0303 or empty AcGFP vector. The latter two served as controls. Confocal microscopy: *left panels* show AcGFP fluorescence, *middle panels* show binding of monoclonal mouse anti-MHC class I antibody W6/32, *right panels* show merge. Flow cytometry: *green lines* show binding of W6/32, *dotted grey lines* are negative controls (empty AcGFP vector) and *dashed grey lines* show secondary antibody control (polyclonal PeCy5-coupled goat anti-mouse antibody). The mean fluorescence intensity (MFI) is given in the *upper right corner*. Results show one of at least three independent experiments. **b** AcGFP-tagged Mamu-A and Mamu-B expression constructs were transiently transfected in K562 and tested for binding of anti-MHC class I monoclonal antibody W6/32 and anti-beta-2-microglobulin antibody BBM.1 in flow cytometry. Relative binding is indicated as ratio of MFI (W6/32 or BBM.1)/MFI (mock transfection). The average of three independent experiments is shown and *error bars* denote SEM

From our cDNA pool we cloned nine *Mamu-B* and two *Mamu-I* cDNAs. Only one of these cloned *Mamu-B* cDNA sequences (*Mamu-B\*03002*) is identical with a gene of the completely sequenced *MHC class I* haplotype (accession no. AB128049; *Mamu-B5*). All other cloned sequences are either alleles from already known *Mamu-B* genes or represent distinct genes. Analysis of the various *Mamu-B*-transfected K562 cells by flow cytometry and confocal microscopy also revealed different protein expression patterns. Among all *Mamu-B* transfectants, B\*01704, B\*02101, B\*04801, B\*06002 and B\*13401 showed the highest level of cell surface expression according to binding of W6/32, with MFI values ranging between 222 and 792 (Fig. [1a](#Fig1){ref-type="fig"}). Cell surface expression of these Mamu-B molecules is comparable to *Mamu-A*-encoded class I molecules (except Mamu-A4\*1403) regarding quantity (MFI range) and quality (confocal microscopy). Also similar to Mamu-A molecules is a rather low level of intracellular expression of these Mamu-B molecules, although B\*01704 and B\*06002 display some intracellular AcGFP fluorescence. A second group of Mamu-B molecules, B\*01202, B\*02804, B\*03002, B\*05704, I\*010201 and I\*0121 are characterised by weak surface expression with MFI values ranging between 100 and 159 and strong intracellular expression similar to what was found for Mamu-A4\*1403 (Fig. [1a](#Fig1){ref-type="fig"}). The same tendency in all Mamu-B MFI values was observed upon staining of the cells with the anti-β2-microglobulin antibody BBM.1 (Fig. [1b](#Fig1){ref-type="fig"}). Thus, *B\*01704*, *B\*02101*, *B\*04801*, *B\*06002* and *B\*13401* show protein expression levels similar to classical *class I* molecules and *B\*01202*, *B\*02804*, *B\*03002*, *B\*05704*, *I\*010201* and *I\*0121* to non-classical ones.

Otting and colleagues ([@CR22]) distinguished *Mamu-B* genes as 'majors' and 'minors' according to mRNA transcription levels and speculated that they are classified accordingly as classical and non-classical *MHC class I* genes. The classification as 'major' (classical class I) only partially overlaps with our protein expression data: *B\*01704*, *B\*02101*, *B\*04801* and *B\*06002*. However, we also found disagreeing results as *B\*01202*, B\**02804* and *B\*03002* are classified as 'majors' with respect to transcription, but are characterised by a very low cell surface and mainly intracellular expression pattern more compatible with a non-classical MHC class I protein. This incongruence might be due to post-transcriptional and post-translational regulatory mechanisms such as RNA interference, inefficient protein translation, or increased protein degradation, respectively. Hence, mRNA transcription level might not necessarily be a highly reliable predictor of cell surface protein expression or classical/non-classical characters.

Although we did not analyse multiple alleles of single rhesus macaque *MHC class I* genes, we do not expect allelic differences to drastically change the protein expression pattern. This assumption is based on the fact that *MHC class I* allelic polymorphism is generally low in rhesus macaques (Otting et al. [@CR22]), but also reflects to a certain extent our limited knowledge of many *Mamu-B* sequences whether they represent alleles or distinct genes. Therefore, we cannot exclude the possibility that allelic differences are indeed associated with changes of cellular expression patterns.

Intracellular localization of rhesus macaque class I molecules is due to ER retention {#Sec11}
-------------------------------------------------------------------------------------

The construction of GFP fusion proteins is a well-established method to visualise expression and to determine subcellular localization of target molecules, especially if specific antibodies are not available. In previous studies, GFP-tagged HLA class I proteins were shown to behave in a similar manner as their wild-type counterparts (Gromme et al. [@CR11]). Nevertheless, to exclude any potential effect of the AcGFP tag, a stop codon was introduced by site-directed mutagenesis in expression constructs *A1\*00101*, *A1\*00801*, *A1\*01101*, *A2\*050402*, *A3\*1311*, *A4\*1403*, *B\*01202*, *B\*02101*, *B\*02804*, *B\*06002*, *I\*010201* and *I\*0121*. No significant differences between tagged and untagged Mamu class I molecules were observed (Fig. [2a](#Fig2){ref-type="fig"}), ruling out a negative effect of AcGFP-tagging on MHC class I cell surface expression. Availability of β2-microglobulin is a regulating factor of cell surface expression of many, but not all MHC class I molecules (Myers et al. [@CR19]). To rule out that inefficient binding of human β2-microglobulin and unavailability of rhesus macaque β2-microglobulin leads to lower expression levels of some Mamu-B molecules on the surface of human K562 cells, we transiently co-transfected rhesus macaque *B2M* along with two high expressing (*B\*01704*, *B\*06002*) and three low expressing constructs (*B\*01202*, *B\*02804*, *I\*010201*). As is shown in Fig. [2b](#Fig2){ref-type="fig"}, presence of rhesus macaque β2-microglobulin has no significant effect on cell surface expression of all studied Mamu-B molecules. Thus, we can exclude the AcGFP tag and unavailability of rhesus macaque B2M as influencing factors of variable Mamu-B expression patterns in K562 cells. Fig. 2AcGFP-tagging and presence of rhesus macaque β2-microglobulin do not affect the surface expression of rhesus macaque MHC class I molecules. **a** Constructs coding for Mamu-A1\*00101, A1\*00801, A1\*01101, A2\*050402, A3\*1311, A4\*1403, B\*01202, B\*02101, B\*02804, B\*06002, I\*010201 and I\*0121 either with or without C-terminal AcGFP were transiently transfected in K562 cells. Surface expression was measured 2 days post-transfection by flow cytometry with W6/32 and polyclonal PeCy5-coupled goat anti-mouse antibody. The MFI ratios of AcGFP-tagged versus untagged MHC class I of four independent experiments are indicated. *Horizontal bars* indicate the average and *vertical bars* denote SEM. **b** K562 cells were transiently transfected with AcGFP-tagged Mamu-B constructs along with either none (control), 2 µg, or 3 µg of rhesus macaque β2-microglobulin expression construct (mmB2M). Expression of mmB2M was controlled in parallel experiments with anti-V5 tag-specific antibody. The average of three independent experiments is shown and error bars denote SEM

Peptide receptive class I molecules are usually retained in the ER (Bijlmakers and Ploegh [@CR1]) due to improper folding, lack of glycosylation, or failure of peptide loading. However, misfolded or empty class I molecules are not completely retained in the ER, they can cycle between the cis-Golgi, the intermediate compartment and the ER (Garstka et al. [@CR9]; Hammond and Helenius [@CR13]). Hence, we studied by confocal microscopy the intracellular distribution of AcGFP-tagged A1\*00101 and B\*01202 (Fig. [3](#Fig3){ref-type="fig"}) as well as B\*06002 and I\*010201 (not shown) by co-staining transfected K562 cells with markers for intracellular compartments. For both Mamu-A1\*00101 (Fig. [3](#Fig3){ref-type="fig"}) and Mamu-B\*06002 (not shown) partial co-localisation with Golgi marker GM130 and with late endosomal/lysosomal marker LAMP-1 can be seen, but is not visible with ER marker calnexin, indicating transport through Golgi apparatus, recycling of A1\*00101 and B\*06002 from cell surface to lysosomes, and fast egress from ER, respectively. Such intracellular staining pattern was expected for cell surface-expressed MHC class I molecules (Gromme et al. [@CR11]). The intracellularly expressed MHC class I molecules B\*01202 (Fig. [3](#Fig3){ref-type="fig"}) and Mamu-I\*010201 (data not shown) show the opposite pattern: co-localisation with calnexin, but not with GM130 or LAMP-1. We conclude from these findings that the intracellularly expressed Mamu-B and Mamu-I molecules are retained within the ER. Fig. 3Co-localisation of AcGFP-tagged Mamu-A1\*00101 and Mamu-B\*01202 molecules with organelle-specific markers by confocal microscopy (×63 magnification). *Left panels* show AcGFP, *middle panels* show markers for ER (*calnexin*), Golgi apparatus (*GM130*), late endosomal/lysosomal compartment (*LAMP-1*) and *right panels* show merge. Co-localisation of class I and the marker protein is shown in *yellow*. Note that co-localisation of B\*01202 and calnexin is evident, but the *yellow colour* is pale

Differential expression patterns can be assigned to the α1 and α2 domains {#Sec12}
-------------------------------------------------------------------------

Intracellular localisation of MHC class I molecules was described for HLA-C and is due to inefficient assembly, slower intracellular transport and stronger association with the TAP complex compared to HLA-A and HLA-B (Neisig et al. [@CR21]; Sibilio et al. [@CR28]). Mutation of single amino acid residues revealed that cysteine residues in the cytoplasmic tail of certain HLA-B and HLA-C alleles are crucial for cell surface expression (Gruda et al. [@CR12]). However, such amino acid residues or corresponding differences in cytoplasmic tails of 'high' or 'low' cell surface expressors are not found in Mamu-B molecules (not shown), suggesting that the extracellular part, in particular the α1 and α2 domains, might be responsible for differential expression patterns of Mamu-B molecules. We tested this hypothesis by using chimeric expression constructs (Fig. [4a](#Fig4){ref-type="fig"}) where we exchanged exons 2 and 3 and chose Mamu-B\*06002 and Mamu-I\*010201 as representatives of high cell surface and high intracellular expression, respectively. The chimeric molecule carrying the α1 and α2 domains of B\*06002 and the C-terminal part of I\*010201 was well expressed on the cell surface like the parental B\*06002 (Fig. [4b](#Fig4){ref-type="fig"}). Thus, the expression pattern is determined by the α1 and α2 domains and not by the α3 domain or transmembrane and cytoplasmic regions. Similar results were obtained for the chimaera with the α1 and the α2 domains derived from I\*010201 and the C-terminus from B\*06002, showing the same expression pattern as the parental I\*010201 (Fig. [4b](#Fig4){ref-type="fig"}). The observed expression patterns can neither be assigned to the α1 nor the α2 domain alone. Exchange of either domain alone resulted in a substantial reduction of MHC class I cell surface expression in almost all cases, which might be due to lower stability of chimeric molecules. An exception is the α2 domain of B\*06002 that conferred a slightly enhanced cell surface expression in the context of an I\*010201 framework, although still not achieving parental B\*06002 MFI values (Fig. [4b](#Fig4){ref-type="fig"}). We conclude from these observations that the peptide-binding groove is responsible for the observed differences in subcellular localization and hypothesise that Mamu-A and Mamu-B molecules with low or nearly absent cell surface expression are not efficiently loaded with peptides and therefore, are retained in the ER. These Mamu-B molecules might preferentially bind rare peptides that are available only in certain physiological or pathological situations, finally resulting in ER release and cell surface expression, analogous to what was previously demonstrated for mouse non-classical H2-M3 (Chiu et al. [@CR6]). In accordance with this hypothesis, the intracellularly expressed Mamu-B\*012 is known for its rather uncommon peptide-binding anchor residue at position P2 (Hickman-Miller et al. [@CR14]). However, even very small amounts of cell-surface MHC class I can be sufficient for CTL recognition as demonstrated in a recent paper by Dressel and colleagues ([@CR8]), showing highly efficient CTL-mediated and peptide-dependent killing of multipotent adult germ-line stem cells that appeared MHC class I negative in flow cytometry analysis. Hence, also rhesus macaque MHC class I molecules with limited amounts on the cell surface might contribute to antigen presentation function. Indeed, the weakly expressed Mamu-B\*012 was previously shown to present a SHIV-derived peptide to rhesus macaque CTLs (Voss and Letvin [@CR31]). The obvious functional significance of lowly expressed MHC class I molecules raises an important immunological question: how can rhesus macaques back up a sufficiently broad T cell receptor repertoire during thymic selection despite facing a plethora of different MHC class I proteins? The key to that enigma may lie in macaques' strategy of MHC diversity: low allelic polymorphism and high haplotypic diversity in terms of copy number variations. This strategy fits well with the recent finding of inherited control of thymic selection by germ-line-encoded amino acids of the T cell receptor (Scott-Browne et al. [@CR27]). A further explanation for occurrence of intracellular class I molecules of rhesus macaques might be adaptation to certain viral infections and viral subversions of the class I antigen presentation machinery by 'spamming' the ER with different types of MHC class I molecules, thereby reducing the probability of viral immune evasins to down-regulate classical rhesus macaque MHC class I proteins. Nevertheless, our data clearly demonstrate that many of the rhesus macaque class I molecules show an unexpected subcellular localization and this indicates functional diversification of the duplicated genes. Future functional studies have to clarify the role of the intracellularly expressed MHC class I proteins and should help to explain disease associations of certain rhesus macaque *MHC class I* haplotypes. Fig. 4Subcellular localization of Mamu-B molecules can be assigned to the α1 and α2 domains. **a** Scheme of chimeric constructs. The chimeric constructs of Mamu-I\*010201 and Mamu-B\*06002 are named according to the exchanged domains (α1, α2 or α1 and α2 domains together). *SP* signal peptide, *TM*/*CT* transmembrane region and cytoplasmic tail, *AcGFP Aequorea coerulescens* green fluorescent protein. **b** K562 cells were transiently transfected and analysed with W6/32 monoclonal antibody and secondary goat anti-mouse Pe-Cy5-coupled antibody 2 days post-transfection by flow cytometry. *Lower panel* shows confocal laser microscopy (×63 magnification) merged images of AcGFP-tagged Mamu class I molecules (*green*) and W6/32 (*red*). Numbering allows for rapid identification of the respective constructs shown in (**a**). All experiments were performed at least three times with similar results and a representative experiment is shown
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